Anthony Fauci, a key member of the White House coronavirus task force, said results from a clinical trial of a potential COVID-19 treatment showed “quite good news.”
Data from an international study of Gilead’s drug remdesivir showed hospitalized patients treated with the drug recovered 31 percent faster than patients given a placebo, Fauci told reporters at the White House on Wednesday, alongside President Trump and Vice President Pence.
The randomized trial of more than 1,000 people showed patients got better four days faster than those who didn’t get the drug – 11 days on the drug vs. 15 days for the placebo.
“Although a 31 percent improvement doesn’t seem like a knockout 100 percent, it is a very important proof of concept,” Fauci said. “What it has proven is that a drug can block this virus.”
Remdesivir patients also saw an 8 percent mortality rate, which is slightly lower, but not statistically significant, from the 11.6 percent mortality rate of placebo patients, Fauci said. The drug’s impact on the COVID-19 mortality rate needs further analysis, he said.